Cargando…
Novel Antifungals and Aspergillus Section Terrei with Potpourri Susceptibility Profiles to Conventional Antifungals
The epidemiology of invasive fungal infections (IFIs) is currently changing, driven by aggressive immunosuppressive therapy, leading to an expanded spectrum of patients at risk of IFIs. Aspergillosis is a leading cause of IFIs, which usually affects immunocompromised patients. There are a limited nu...
Autores principales: | Vahedi-Shahandashti, Roya, Houbraken, Jos, Birch, Mike, Lass-Flörl, Cornelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303807/ https://www.ncbi.nlm.nih.gov/pubmed/37367585 http://dx.doi.org/10.3390/jof9060649 |
Ejemplares similares
-
Aspergillus Section Terrei and Antifungals: From Broth to Agar-Based Susceptibility Testing Methods
por: Vahedi-Shahandashti, Roya, et al.
Publicado: (2023) -
P384 Characterization of the virulence potential of Aspergillus species of section Terrei in Galleria mellonella infection model
por: Shahandashti, Roya Vahedi, et al.
Publicado: (2022) -
Novel Antifungal Agents and Their Activity against Aspergillus Species
por: Vahedi-Shahandashti, Roya, et al.
Publicado: (2020) -
The Influence of Medium Composition on EUCAST and Etest Antifungal Susceptibility Testing
por: Vahedi-Shahandashti, Roya, et al.
Publicado: (2023) -
The Emergence of Rare Clinical Aspergillus Species in Qatar: Molecular Characterization and Antifungal Susceptibility Profiles
por: Salah, Husam, et al.
Publicado: (2019)